nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS3—breast cancer	0.358	1	CbGaD
Metformin—NDUFS7—Doxorubicin—breast cancer	0.0613	0.218	CbGbCtD
Metformin—NDUFS2—Doxorubicin—breast cancer	0.0613	0.218	CbGbCtD
Metformin—NDUFS3—Doxorubicin—breast cancer	0.0613	0.218	CbGbCtD
Metformin—SLC22A3—Melphalan—breast cancer	0.0413	0.147	CbGbCtD
Metformin—SLC47A1—Mitoxantrone—breast cancer	0.034	0.121	CbGbCtD
Metformin—SLC22A3—Irinotecan—breast cancer	0.014	0.0498	CbGbCtD
Metformin—SLC22A2—Vinblastine—breast cancer	0.00736	0.0262	CbGbCtD
Metformin—NDUFA2—Vincristine—Vinorelbine—breast cancer	0.000733	0.338	CbGdCrCtD
Metformin—NDUFA2—Vincristine—Vinblastine—breast cancer	0.000586	0.271	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Gemcitabine—breast cancer	0.000325	0.15	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Gemcitabine—breast cancer	0.000276	0.127	CbGdCrCtD
Metformin—NDUFB3—Azacitidine—Gemcitabine—breast cancer	0.000246	0.114	CbGdCrCtD
Metformin—NDUFB11—pituitary gland—breast cancer	0.000207	0.002	CbGeAlD
Metformin—NDUFV1—pituitary gland—breast cancer	0.000207	0.002	CbGeAlD
Metformin—NDUFAF4—female reproductive system—breast cancer	0.000207	0.002	CbGeAlD
Metformin—NDUFB6—female reproductive system—breast cancer	0.000207	0.002	CbGeAlD
Metformin—NDUFB11—adipose tissue—breast cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFV1—adipose tissue—breast cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFB2—bone marrow—breast cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFS5—pituitary gland—breast cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFB8—pituitary gland—breast cancer	0.000206	0.00199	CbGeAlD
Metformin—NDUFS1—female reproductive system—breast cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFB8—adipose tissue—breast cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFS5—adipose tissue—breast cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFC2—epithelium—breast cancer	0.000205	0.00198	CbGeAlD
Metformin—NDUFAF1—bone marrow—breast cancer	0.000204	0.00198	CbGeAlD
Metformin—NDUFB10—female reproductive system—breast cancer	0.000204	0.00197	CbGeAlD
Metformin—NDUFA11—adrenal gland—breast cancer	0.000203	0.00197	CbGeAlD
Metformin—NDUFA5—adrenal gland—breast cancer	0.000203	0.00197	CbGeAlD
Metformin—ND6—bone marrow—breast cancer	0.000203	0.00196	CbGeAlD
Metformin—NDUFA10—female gonad—breast cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFA12—female reproductive system—breast cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFB7—female reproductive system—breast cancer	0.000202	0.00196	CbGeAlD
Metformin—NDUFAF4—adrenal gland—breast cancer	0.000202	0.00195	CbGeAlD
Metformin—NDUFB6—adrenal gland—breast cancer	0.000202	0.00195	CbGeAlD
Metformin—ND4—endocrine gland—breast cancer	0.000201	0.00195	CbGeAlD
Metformin—NDUFB3—bone marrow—breast cancer	0.000201	0.00195	CbGeAlD
Metformin—NDUFAF2—bone marrow—breast cancer	0.000201	0.00195	CbGeAlD
Metformin—NDUFS8—female reproductive system—breast cancer	0.000201	0.00194	CbGeAlD
Metformin—NDUFC1—female gonad—breast cancer	0.0002	0.00194	CbGeAlD
Metformin—NDUFS1—adrenal gland—breast cancer	0.0002	0.00194	CbGeAlD
Metformin—NDUFB2—female gonad—breast cancer	0.000199	0.00192	CbGeAlD
Metformin—NDUFB10—adrenal gland—breast cancer	0.000199	0.00192	CbGeAlD
Metformin—NDUFB5—female reproductive system—breast cancer	0.000198	0.00192	CbGeAlD
Metformin—NDUFA6—female reproductive system—breast cancer	0.000198	0.00192	CbGeAlD
Metformin—NDUFB7—adrenal gland—breast cancer	0.000197	0.00191	CbGeAlD
Metformin—NDUFA12—adrenal gland—breast cancer	0.000197	0.00191	CbGeAlD
Metformin—NDUFA2—endocrine gland—breast cancer	0.000197	0.00191	CbGeAlD
Metformin—NDUFAF1—female gonad—breast cancer	0.000197	0.00191	CbGeAlD
Metformin—NDUFS4—female reproductive system—breast cancer	0.000197	0.0019	CbGeAlD
Metformin—NDUFA7—lymph node—breast cancer	0.000197	0.0019	CbGeAlD
Metformin—NDUFA5—bone marrow—breast cancer	0.000196	0.0019	CbGeAlD
Metformin—NDUFS8—adrenal gland—breast cancer	0.000196	0.0019	CbGeAlD
Metformin—NDUFB1—adrenal gland—breast cancer	0.000196	0.0019	CbGeAlD
Metformin—ND6—female gonad—breast cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFAF4—bone marrow—breast cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFB6—bone marrow—breast cancer	0.000195	0.00189	CbGeAlD
Metformin—PRKAB1—endometrium—breast cancer	0.000195	0.00189	CbGeAlD
Metformin—NDUFB4—female reproductive system—breast cancer	0.000194	0.00188	CbGeAlD
Metformin—NDUFB3—female gonad—breast cancer	0.000194	0.00188	CbGeAlD
Metformin—NDUFAF2—female gonad—breast cancer	0.000194	0.00188	CbGeAlD
Metformin—NDUFS1—bone marrow—breast cancer	0.000194	0.00187	CbGeAlD
Metformin—NDUFB5—adrenal gland—breast cancer	0.000193	0.00187	CbGeAlD
Metformin—NDUFA6—adrenal gland—breast cancer	0.000193	0.00187	CbGeAlD
Metformin—NDUFAB1—female reproductive system—breast cancer	0.000193	0.00187	CbGeAlD
Metformin—NDUFB10—bone marrow—breast cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFS7—adipose tissue—breast cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFS4—adrenal gland—breast cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFB9—female reproductive system—breast cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFA8—female reproductive system—breast cancer	0.000192	0.00186	CbGeAlD
Metformin—NDUFB7—bone marrow—breast cancer	0.000191	0.00185	CbGeAlD
Metformin—NDUFA12—bone marrow—breast cancer	0.000191	0.00185	CbGeAlD
Metformin—NDUFA4—female reproductive system—breast cancer	0.000191	0.00184	CbGeAlD
Metformin—NDUFB4—adrenal gland—breast cancer	0.00019	0.00183	CbGeAlD
Metformin—NDUFB1—bone marrow—breast cancer	0.00019	0.00183	CbGeAlD
Metformin—NDUFS8—bone marrow—breast cancer	0.00019	0.00183	CbGeAlD
Metformin—NDUFV1—female reproductive system—breast cancer	0.000189	0.00183	CbGeAlD
Metformin—NDUFB11—female reproductive system—breast cancer	0.000189	0.00183	CbGeAlD
Metformin—NDUFA11—female gonad—breast cancer	0.000189	0.00183	CbGeAlD
Metformin—NDUFA5—female gonad—breast cancer	0.000189	0.00183	CbGeAlD
Metformin—NDUFB8—female reproductive system—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFS5—female reproductive system—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFAB1—adrenal gland—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFA10—endocrine gland—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFAF4—female gonad—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFB6—female gonad—breast cancer	0.000188	0.00182	CbGeAlD
Metformin—NDUFS2—skin of body—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFA8—adrenal gland—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFB9—adrenal gland—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFB5—bone marrow—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFA6—bone marrow—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFS1—female gonad—breast cancer	0.000187	0.00181	CbGeAlD
Metformin—NDUFA4—adrenal gland—breast cancer	0.000186	0.0018	CbGeAlD
Metformin—NDUFS4—bone marrow—breast cancer	0.000186	0.0018	CbGeAlD
Metformin—NDUFB10—female gonad—breast cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFS3—skin of body—breast cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFB11—adrenal gland—breast cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFV1—adrenal gland—breast cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFB2—endocrine gland—breast cancer	0.000185	0.00179	CbGeAlD
Metformin—NDUFB7—female gonad—breast cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFA12—female gonad—breast cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFB8—adrenal gland—breast cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFS5—adrenal gland—breast cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFC2—endometrium—breast cancer	0.000184	0.00178	CbGeAlD
Metformin—NDUFB4—bone marrow—breast cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFAF1—endocrine gland—breast cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFB1—female gonad—breast cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFS8—female gonad—breast cancer	0.000183	0.00177	CbGeAlD
Metformin—NDUFAB1—bone marrow—breast cancer	0.000182	0.00176	CbGeAlD
Metformin—ND6—endocrine gland—breast cancer	0.000182	0.00176	CbGeAlD
Metformin—NDUFB9—bone marrow—breast cancer	0.000181	0.00175	CbGeAlD
Metformin—NDUFA8—bone marrow—breast cancer	0.000181	0.00175	CbGeAlD
Metformin—NDUFB3—endocrine gland—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—NDUFAF2—endocrine gland—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—NDUFB5—female gonad—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—NDUFA6—female gonad—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—NDUFA4—bone marrow—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—PRKAB1—uterus—breast cancer	0.00018	0.00174	CbGeAlD
Metformin—NDUFS4—female gonad—breast cancer	0.000179	0.00173	CbGeAlD
Metformin—NDUFB11—bone marrow—breast cancer	0.000179	0.00173	CbGeAlD
Metformin—NDUFV1—bone marrow—breast cancer	0.000179	0.00173	CbGeAlD
Metformin—NDUFS5—bone marrow—breast cancer	0.000178	0.00172	CbGeAlD
Metformin—NDUFB8—bone marrow—breast cancer	0.000178	0.00172	CbGeAlD
Metformin—NDUFB4—female gonad—breast cancer	0.000177	0.00171	CbGeAlD
Metformin—NDUFS2—endometrium—breast cancer	0.000177	0.00171	CbGeAlD
Metformin—NDUFS7—female reproductive system—breast cancer	0.000177	0.00171	CbGeAlD
Metformin—PRKAB1—pituitary gland—breast cancer	0.000176	0.00171	CbGeAlD
Metformin—NDUFA11—endocrine gland—breast cancer	0.000176	0.0017	CbGeAlD
Metformin—NDUFA5—endocrine gland—breast cancer	0.000176	0.0017	CbGeAlD
Metformin—PRKAB1—adipose tissue—breast cancer	0.000176	0.0017	CbGeAlD
Metformin—NDUFAB1—female gonad—breast cancer	0.000176	0.0017	CbGeAlD
Metformin—NDUFB6—endocrine gland—breast cancer	0.000175	0.00169	CbGeAlD
Metformin—NDUFAF4—endocrine gland—breast cancer	0.000175	0.00169	CbGeAlD
Metformin—NDUFB9—female gonad—breast cancer	0.000175	0.00169	CbGeAlD
Metformin—NDUFA8—female gonad—breast cancer	0.000175	0.00169	CbGeAlD
Metformin—NDUFS3—endometrium—breast cancer	0.000174	0.00169	CbGeAlD
Metformin—NDUFS1—endocrine gland—breast cancer	0.000174	0.00168	CbGeAlD
Metformin—NDUFA4—female gonad—breast cancer	0.000173	0.00168	CbGeAlD
Metformin—NDUFV1—female gonad—breast cancer	0.000172	0.00167	CbGeAlD
Metformin—NDUFB11—female gonad—breast cancer	0.000172	0.00167	CbGeAlD
Metformin—NDUFB10—endocrine gland—breast cancer	0.000172	0.00167	CbGeAlD
Metformin—NDUFS7—adrenal gland—breast cancer	0.000172	0.00167	CbGeAlD
Metformin—NDUFS5—female gonad—breast cancer	0.000171	0.00166	CbGeAlD
Metformin—NDUFB8—female gonad—breast cancer	0.000171	0.00166	CbGeAlD
Metformin—NDUFA12—endocrine gland—breast cancer	0.000171	0.00166	CbGeAlD
Metformin—NDUFB7—endocrine gland—breast cancer	0.000171	0.00166	CbGeAlD
Metformin—NDUFB1—endocrine gland—breast cancer	0.00017	0.00164	CbGeAlD
Metformin—NDUFS8—endocrine gland—breast cancer	0.00017	0.00164	CbGeAlD
Metformin—NDUFC2—uterus—breast cancer	0.000169	0.00164	CbGeAlD
Metformin—NDUFA6—endocrine gland—breast cancer	0.000168	0.00162	CbGeAlD
Metformin—NDUFB5—endocrine gland—breast cancer	0.000168	0.00162	CbGeAlD
Metformin—NDUFS7—bone marrow—breast cancer	0.000167	0.00161	CbGeAlD
Metformin—NDUFS4—endocrine gland—breast cancer	0.000166	0.00161	CbGeAlD
Metformin—NDUFC2—pituitary gland—breast cancer	0.000166	0.00161	CbGeAlD
Metformin—NDUFC2—adipose tissue—breast cancer	0.000166	0.0016	CbGeAlD
Metformin—NDUFB4—endocrine gland—breast cancer	0.000164	0.00159	CbGeAlD
Metformin—NDUFAB1—endocrine gland—breast cancer	0.000163	0.00158	CbGeAlD
Metformin—SLC47A1—nipple—breast cancer	0.000163	0.00158	CbGeAlD
Metformin—NDUFS2—uterus—breast cancer	0.000163	0.00157	CbGeAlD
Metformin—NDUFB9—endocrine gland—breast cancer	0.000162	0.00157	CbGeAlD
Metformin—NDUFA8—endocrine gland—breast cancer	0.000162	0.00157	CbGeAlD
Metformin—PRKAB1—female reproductive system—breast cancer	0.000161	0.00156	CbGeAlD
Metformin—NDUFA4—endocrine gland—breast cancer	0.000161	0.00156	CbGeAlD
Metformin—NDUFS3—uterus—breast cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFS7—female gonad—breast cancer	0.000161	0.00155	CbGeAlD
Metformin—NDUFV1—endocrine gland—breast cancer	0.00016	0.00155	CbGeAlD
Metformin—NDUFB11—endocrine gland—breast cancer	0.00016	0.00155	CbGeAlD
Metformin—NDUFS2—pituitary gland—breast cancer	0.00016	0.00155	CbGeAlD
Metformin—NDUFS5—endocrine gland—breast cancer	0.000159	0.00154	CbGeAlD
Metformin—NDUFB8—endocrine gland—breast cancer	0.000159	0.00154	CbGeAlD
Metformin—NDUFS2—adipose tissue—breast cancer	0.000159	0.00154	CbGeAlD
Metformin—NDUFS3—pituitary gland—breast cancer	0.000158	0.00153	CbGeAlD
Metformin—PRKAB1—adrenal gland—breast cancer	0.000158	0.00152	CbGeAlD
Metformin—NDUFS3—adipose tissue—breast cancer	0.000157	0.00152	CbGeAlD
Metformin—NDUFV2—lymph node—breast cancer	0.000157	0.00152	CbGeAlD
Metformin—ND1—skin of body—breast cancer	0.000154	0.00149	CbGeAlD
Metformin—NDUFA4L2—lymph node—breast cancer	0.000153	0.00148	CbGeAlD
Metformin—PRKAB1—bone marrow—breast cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFC2—female reproductive system—breast cancer	0.000152	0.00147	CbGeAlD
Metformin—NDUFS7—endocrine gland—breast cancer	0.000149	0.00145	CbGeAlD
Metformin—NDUFC2—adrenal gland—breast cancer	0.000148	0.00144	CbGeAlD
Metformin—PRKAB1—female gonad—breast cancer	0.000147	0.00142	CbGeAlD
Metformin—NDUFS2—female reproductive system—breast cancer	0.000146	0.00142	CbGeAlD
Metformin—NDUFS3—female reproductive system—breast cancer	0.000144	0.0014	CbGeAlD
Metformin—ND3—lymph node—breast cancer	0.000144	0.00139	CbGeAlD
Metformin—ND4L—lymph node—breast cancer	0.000144	0.00139	CbGeAlD
Metformin—ND5—lymph node—breast cancer	0.000144	0.00139	CbGeAlD
Metformin—ND2—lymph node—breast cancer	0.000144	0.00139	CbGeAlD
Metformin—NDUFC2—bone marrow—breast cancer	0.000144	0.00139	CbGeAlD
Metformin—NDUFS2—adrenal gland—breast cancer	0.000143	0.00138	CbGeAlD
Metformin—NDUFS3—adrenal gland—breast cancer	0.000141	0.00136	CbGeAlD
Metformin—ND4—lymph node—breast cancer	0.000139	0.00135	CbGeAlD
Metformin—NDUFC2—female gonad—breast cancer	0.000138	0.00134	CbGeAlD
Metformin—NDUFS2—bone marrow—breast cancer	0.000138	0.00134	CbGeAlD
Metformin—PRKAB1—endocrine gland—breast cancer	0.000137	0.00132	CbGeAlD
Metformin—NDUFS3—bone marrow—breast cancer	0.000136	0.00132	CbGeAlD
Metformin—NDUFA2—lymph node—breast cancer	0.000136	0.00132	CbGeAlD
Metformin—NDUFS2—female gonad—breast cancer	0.000133	0.00129	CbGeAlD
Metformin—NDUFS3—female gonad—breast cancer	0.000131	0.00127	CbGeAlD
Metformin—NDUFA10—lymph node—breast cancer	0.00013	0.00126	CbGeAlD
Metformin—SLC22A3—nipple—breast cancer	0.00013	0.00126	CbGeAlD
Metformin—NDUFC1—lymph node—breast cancer	0.000129	0.00125	CbGeAlD
Metformin—NDUFC2—endocrine gland—breast cancer	0.000129	0.00125	CbGeAlD
Metformin—NDUFB2—lymph node—breast cancer	0.000128	0.00124	CbGeAlD
Metformin—NDUFAF1—lymph node—breast cancer	0.000127	0.00123	CbGeAlD
Metformin—ND6—lymph node—breast cancer	0.000126	0.00122	CbGeAlD
Metformin—NDUFAF2—lymph node—breast cancer	0.000125	0.00121	CbGeAlD
Metformin—NDUFB3—lymph node—breast cancer	0.000125	0.00121	CbGeAlD
Metformin—NDUFS2—endocrine gland—breast cancer	0.000124	0.0012	CbGeAlD
Metformin—NDUFS3—endocrine gland—breast cancer	0.000122	0.00118	CbGeAlD
Metformin—NDUFA5—lymph node—breast cancer	0.000122	0.00118	CbGeAlD
Metformin—NDUFA11—lymph node—breast cancer	0.000122	0.00118	CbGeAlD
Metformin—NDUFB6—lymph node—breast cancer	0.000121	0.00117	CbGeAlD
Metformin—NDUFAF4—lymph node—breast cancer	0.000121	0.00117	CbGeAlD
Metformin—ND1—female reproductive system—breast cancer	0.00012	0.00116	CbGeAlD
Metformin—NDUFS1—lymph node—breast cancer	0.00012	0.00116	CbGeAlD
Metformin—NDUFB10—lymph node—breast cancer	0.000119	0.00115	CbGeAlD
Metformin—NDUFB7—lymph node—breast cancer	0.000118	0.00114	CbGeAlD
Metformin—NDUFA12—lymph node—breast cancer	0.000118	0.00114	CbGeAlD
Metformin—NDUFS8—lymph node—breast cancer	0.000117	0.00114	CbGeAlD
Metformin—NDUFB1—lymph node—breast cancer	0.000117	0.00114	CbGeAlD
Metformin—ND1—adrenal gland—breast cancer	0.000117	0.00113	CbGeAlD
Metformin—NDUFB5—lymph node—breast cancer	0.000116	0.00112	CbGeAlD
Metformin—NDUFA6—lymph node—breast cancer	0.000116	0.00112	CbGeAlD
Metformin—NDUFS4—lymph node—breast cancer	0.000115	0.00111	CbGeAlD
Metformin—NDUFB4—lymph node—breast cancer	0.000114	0.0011	CbGeAlD
Metformin—ND1—bone marrow—breast cancer	0.000113	0.0011	CbGeAlD
Metformin—NDUFAB1—lymph node—breast cancer	0.000113	0.00109	CbGeAlD
Metformin—NDUFB9—lymph node—breast cancer	0.000112	0.00109	CbGeAlD
Metformin—NDUFA8—lymph node—breast cancer	0.000112	0.00109	CbGeAlD
Metformin—NDUFA4—lymph node—breast cancer	0.000112	0.00108	CbGeAlD
Metformin—NDUFB11—lymph node—breast cancer	0.000111	0.00107	CbGeAlD
Metformin—NDUFV1—lymph node—breast cancer	0.000111	0.00107	CbGeAlD
Metformin—NDUFS5—lymph node—breast cancer	0.00011	0.00107	CbGeAlD
Metformin—NDUFB8—lymph node—breast cancer	0.00011	0.00107	CbGeAlD
Metformin—ND1—female gonad—breast cancer	0.000109	0.00106	CbGeAlD
Metformin—SLC22A3—embryo—breast cancer	0.000107	0.00104	CbGeAlD
Metformin—NDUFS7—lymph node—breast cancer	0.000103	0.000999	CbGeAlD
Metformin—ND1—endocrine gland—breast cancer	0.000102	0.000982	CbGeAlD
Metformin—SLC47A1—endometrium—breast cancer	9.84e-05	0.000952	CbGeAlD
Metformin—PRKAB1—lymph node—breast cancer	9.44e-05	0.000914	CbGeAlD
Metformin—SLC47A1—uterus—breast cancer	9.07e-05	0.000877	CbGeAlD
Metformin—SLC47A1—pituitary gland—breast cancer	8.9e-05	0.000862	CbGeAlD
Metformin—NDUFC2—lymph node—breast cancer	8.9e-05	0.000861	CbGeAlD
Metformin—SLC47A1—adipose tissue—breast cancer	8.87e-05	0.000858	CbGeAlD
Metformin—NDUFS2—lymph node—breast cancer	8.56e-05	0.000828	CbGeAlD
Metformin—NDUFS3—lymph node—breast cancer	8.45e-05	0.000818	CbGeAlD
Metformin—SLC47A1—female reproductive system—breast cancer	8.15e-05	0.000789	CbGeAlD
Metformin—SLC47A1—adrenal gland—breast cancer	7.95e-05	0.00077	CbGeAlD
Metformin—SLC22A3—endometrium—breast cancer	7.85e-05	0.000759	CbGeAlD
Metformin—SLC47A1—female gonad—breast cancer	7.42e-05	0.000718	CbGeAlD
Metformin—SLC22A1—adipose tissue—breast cancer	7.4e-05	0.000716	CbGeAlD
Metformin—SLC22A3—adipose tissue—breast cancer	7.07e-05	0.000684	CbGeAlD
Metformin—ND1—lymph node—breast cancer	7.02e-05	0.000679	CbGeAlD
Metformin—SLC47A1—endocrine gland—breast cancer	6.9e-05	0.000667	CbGeAlD
Metformin—SLC22A3—female reproductive system—breast cancer	6.5e-05	0.000629	CbGeAlD
Metformin—SLC22A3—adrenal gland—breast cancer	6.34e-05	0.000614	CbGeAlD
Metformin—SLC22A3—female gonad—breast cancer	5.91e-05	0.000572	CbGeAlD
Metformin—SLC22A1—endocrine gland—breast cancer	5.76e-05	0.000557	CbGeAlD
Metformin—SLC22A3—endocrine gland—breast cancer	5.5e-05	0.000532	CbGeAlD
Metformin—SLC47A1—lymph node—breast cancer	4.77e-05	0.000461	CbGeAlD
Metformin—SLC22A3—lymph node—breast cancer	3.8e-05	0.000368	CbGeAlD
Metformin—Neuropathy peripheral—Doxorubicin—breast cancer	3.4e-05	0.000299	CcSEcCtD
Metformin—Dizziness—Irinotecan—breast cancer	3.39e-05	0.000298	CcSEcCtD
Metformin—Anorexia—Docetaxel—breast cancer	3.38e-05	0.000297	CcSEcCtD
Metformin—Shock—Capecitabine—breast cancer	3.38e-05	0.000297	CcSEcCtD
Metformin—Rhinitis—Epirubicin—breast cancer	3.37e-05	0.000297	CcSEcCtD
Metformin—Nervous system disorder—Capecitabine—breast cancer	3.37e-05	0.000296	CcSEcCtD
Metformin—Hepatitis—Epirubicin—breast cancer	3.37e-05	0.000296	CcSEcCtD
Metformin—Eye disorder—Methotrexate—breast cancer	3.36e-05	0.000295	CcSEcCtD
Metformin—Diarrhoea—Fluorouracil—breast cancer	3.36e-05	0.000295	CcSEcCtD
Metformin—Thrombocytopenia—Capecitabine—breast cancer	3.36e-05	0.000295	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—breast cancer	3.35e-05	0.000294	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—breast cancer	3.34e-05	0.000293	CcSEcCtD
Metformin—Skin disorder—Capecitabine—breast cancer	3.33e-05	0.000293	CcSEcCtD
Metformin—Urticaria—Paclitaxel—breast cancer	3.32e-05	0.000292	CcSEcCtD
Metformin—Hyperhidrosis—Capecitabine—breast cancer	3.32e-05	0.000292	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—breast cancer	3.32e-05	0.000291	CcSEcCtD
Metformin—Hypotension—Docetaxel—breast cancer	3.31e-05	0.000291	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—breast cancer	3.31e-05	0.000291	CcSEcCtD
Metformin—Abdominal pain—Paclitaxel—breast cancer	3.31e-05	0.000291	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—breast cancer	3.28e-05	0.000288	CcSEcCtD
Metformin—Anorexia—Capecitabine—breast cancer	3.27e-05	0.000288	CcSEcCtD
Metformin—Angiopathy—Methotrexate—breast cancer	3.26e-05	0.000287	CcSEcCtD
Metformin—Vomiting—Irinotecan—breast cancer	3.26e-05	0.000287	CcSEcCtD
Metformin—Vomiting—Mitoxantrone—breast cancer	3.26e-05	0.000287	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—breast cancer	3.25e-05	0.000285	CcSEcCtD
Metformin—Dizziness—Fluorouracil—breast cancer	3.25e-05	0.000285	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—breast cancer	3.24e-05	0.000285	CcSEcCtD
Metformin—Rash—Irinotecan—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Rash—Mitoxantrone—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Dermatitis—Mitoxantrone—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Dermatitis—Irinotecan—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Chills—Methotrexate—breast cancer	3.23e-05	0.000284	CcSEcCtD
Metformin—Headache—Irinotecan—breast cancer	3.21e-05	0.000282	CcSEcCtD
Metformin—Headache—Mitoxantrone—breast cancer	3.21e-05	0.000282	CcSEcCtD
Metformin—Hypotension—Capecitabine—breast cancer	3.21e-05	0.000282	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—breast cancer	3.18e-05	0.00028	CcSEcCtD
Metformin—Vomiting—Gemcitabine—breast cancer	3.18e-05	0.000279	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—breast cancer	3.17e-05	0.000279	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—breast cancer	3.16e-05	0.000278	CcSEcCtD
Metformin—Somnolence—Docetaxel—breast cancer	3.15e-05	0.000277	CcSEcCtD
Metformin—Rash—Gemcitabine—breast cancer	3.15e-05	0.000277	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—breast cancer	3.15e-05	0.000277	CcSEcCtD
Metformin—Eye disorder—Epirubicin—breast cancer	3.14e-05	0.000276	CcSEcCtD
Metformin—Erythema—Methotrexate—breast cancer	3.13e-05	0.000275	CcSEcCtD
Metformin—Malnutrition—Methotrexate—breast cancer	3.13e-05	0.000275	CcSEcCtD
Metformin—Headache—Gemcitabine—breast cancer	3.13e-05	0.000275	CcSEcCtD
Metformin—Musculoskeletal discomfort—Capecitabine—breast cancer	3.13e-05	0.000275	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—breast cancer	3.12e-05	0.000275	CcSEcCtD
Metformin—Flushing—Epirubicin—breast cancer	3.12e-05	0.000275	CcSEcCtD
Metformin—Vomiting—Fluorouracil—breast cancer	3.12e-05	0.000274	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—breast cancer	3.12e-05	0.000274	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—breast cancer	3.12e-05	0.000274	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—breast cancer	3.11e-05	0.000274	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—breast cancer	3.1e-05	0.000272	CcSEcCtD
Metformin—Rash—Fluorouracil—breast cancer	3.1e-05	0.000272	CcSEcCtD
Metformin—Dermatitis—Fluorouracil—breast cancer	3.09e-05	0.000272	CcSEcCtD
Metformin—Paraesthesia—Capecitabine—breast cancer	3.08e-05	0.000271	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—breast cancer	3.08e-05	0.000271	CcSEcCtD
Metformin—Headache—Fluorouracil—breast cancer	3.08e-05	0.00027	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—breast cancer	3.07e-05	0.00027	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—breast cancer	3.07e-05	0.000269	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—breast cancer	3.06e-05	0.000269	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—breast cancer	3.06e-05	0.000269	CcSEcCtD
Metformin—Dyspnoea—Capecitabine—breast cancer	3.06e-05	0.000269	CcSEcCtD
Metformin—Fatigue—Docetaxel—breast cancer	3.06e-05	0.000269	CcSEcCtD
Metformin—Angiopathy—Epirubicin—breast cancer	3.05e-05	0.000268	CcSEcCtD
Metformin—Nausea—Irinotecan—breast cancer	3.05e-05	0.000268	CcSEcCtD
Metformin—Nausea—Mitoxantrone—breast cancer	3.05e-05	0.000268	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—breast cancer	3.04e-05	0.000267	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—breast cancer	3.03e-05	0.000267	CcSEcCtD
Metformin—Constipation—Docetaxel—breast cancer	3.03e-05	0.000266	CcSEcCtD
Metformin—Dyspepsia—Capecitabine—breast cancer	3.02e-05	0.000266	CcSEcCtD
Metformin—Chills—Epirubicin—breast cancer	3.02e-05	0.000265	CcSEcCtD
Metformin—Asthenia—Paclitaxel—breast cancer	3e-05	0.000264	CcSEcCtD
Metformin—Decreased appetite—Capecitabine—breast cancer	2.98e-05	0.000262	CcSEcCtD
Metformin—Nausea—Gemcitabine—breast cancer	2.97e-05	0.000261	CcSEcCtD
Metformin—Gastrointestinal disorder—Capecitabine—breast cancer	2.96e-05	0.00026	CcSEcCtD
Metformin—Fatigue—Capecitabine—breast cancer	2.96e-05	0.00026	CcSEcCtD
Metformin—Pruritus—Paclitaxel—breast cancer	2.96e-05	0.00026	CcSEcCtD
Metformin—Vision blurred—Methotrexate—breast cancer	2.95e-05	0.000259	CcSEcCtD
Metformin—Constipation—Capecitabine—breast cancer	2.93e-05	0.000258	CcSEcCtD
Metformin—Malnutrition—Epirubicin—breast cancer	2.93e-05	0.000257	CcSEcCtD
Metformin—Erythema—Epirubicin—breast cancer	2.93e-05	0.000257	CcSEcCtD
Metformin—Feeling abnormal—Docetaxel—breast cancer	2.92e-05	0.000257	CcSEcCtD
Metformin—Nausea—Fluorouracil—breast cancer	2.92e-05	0.000256	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—breast cancer	2.91e-05	0.000256	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—breast cancer	2.9e-05	0.000255	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—breast cancer	2.9e-05	0.000255	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—breast cancer	2.89e-05	0.000254	CcSEcCtD
Metformin—Flushing—Doxorubicin—breast cancer	2.89e-05	0.000254	CcSEcCtD
Metformin—Flatulence—Epirubicin—breast cancer	2.89e-05	0.000254	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—breast cancer	2.87e-05	0.000252	CcSEcCtD
Metformin—Diarrhoea—Paclitaxel—breast cancer	2.86e-05	0.000251	CcSEcCtD
Metformin—Feeling abnormal—Capecitabine—breast cancer	2.83e-05	0.000249	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—breast cancer	2.83e-05	0.000248	CcSEcCtD
Metformin—Malaise—Methotrexate—breast cancer	2.82e-05	0.000248	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—breast cancer	2.82e-05	0.000248	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—breast cancer	2.81e-05	0.000247	CcSEcCtD
Metformin—Gastrointestinal pain—Capecitabine—breast cancer	2.81e-05	0.000247	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—breast cancer	2.81e-05	0.000247	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—breast cancer	2.8e-05	0.000246	CcSEcCtD
Metformin—Chills—Doxorubicin—breast cancer	2.79e-05	0.000246	CcSEcCtD
Metformin—Dizziness—Paclitaxel—breast cancer	2.77e-05	0.000243	CcSEcCtD
Metformin—Vision blurred—Epirubicin—breast cancer	2.76e-05	0.000243	CcSEcCtD
Metformin—Urticaria—Capecitabine—breast cancer	2.73e-05	0.00024	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—breast cancer	2.72e-05	0.000239	CcSEcCtD
Metformin—Abdominal pain—Capecitabine—breast cancer	2.71e-05	0.000238	CcSEcCtD
Metformin—Erythema—Doxorubicin—breast cancer	2.71e-05	0.000238	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—breast cancer	2.71e-05	0.000238	CcSEcCtD
Metformin—Flatulence—Doxorubicin—breast cancer	2.67e-05	0.000235	CcSEcCtD
Metformin—Chest pain—Methotrexate—breast cancer	2.67e-05	0.000234	CcSEcCtD
Metformin—Myalgia—Methotrexate—breast cancer	2.67e-05	0.000234	CcSEcCtD
Metformin—Vomiting—Paclitaxel—breast cancer	2.66e-05	0.000234	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—breast cancer	2.65e-05	0.000233	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.65e-05	0.000233	CcSEcCtD
Metformin—Malaise—Epirubicin—breast cancer	2.64e-05	0.000232	CcSEcCtD
Metformin—Rash—Paclitaxel—breast cancer	2.64e-05	0.000232	CcSEcCtD
Metformin—Dermatitis—Paclitaxel—breast cancer	2.63e-05	0.000232	CcSEcCtD
Metformin—Discomfort—Methotrexate—breast cancer	2.63e-05	0.000231	CcSEcCtD
Metformin—Syncope—Epirubicin—breast cancer	2.63e-05	0.000231	CcSEcCtD
Metformin—Headache—Paclitaxel—breast cancer	2.62e-05	0.00023	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—breast cancer	2.61e-05	0.000229	CcSEcCtD
Metformin—Palpitations—Epirubicin—breast cancer	2.59e-05	0.000228	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—breast cancer	2.57e-05	0.000226	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—breast cancer	2.55e-05	0.000225	CcSEcCtD
Metformin—Asthenia—Docetaxel—breast cancer	2.54e-05	0.000224	CcSEcCtD
Metformin—Infection—Methotrexate—breast cancer	2.54e-05	0.000223	CcSEcCtD
Metformin—Hypertension—Epirubicin—breast cancer	2.53e-05	0.000222	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—breast cancer	2.52e-05	0.000221	CcSEcCtD
Metformin—Pruritus—Docetaxel—breast cancer	2.51e-05	0.00022	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—breast cancer	2.51e-05	0.00022	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—breast cancer	2.5e-05	0.00022	CcSEcCtD
Metformin—Chest pain—Epirubicin—breast cancer	2.49e-05	0.000219	CcSEcCtD
Metformin—Myalgia—Epirubicin—breast cancer	2.49e-05	0.000219	CcSEcCtD
Metformin—Nausea—Paclitaxel—breast cancer	2.48e-05	0.000218	CcSEcCtD
Metformin—Skin disorder—Methotrexate—breast cancer	2.48e-05	0.000218	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.48e-05	0.000218	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—breast cancer	2.47e-05	0.000217	CcSEcCtD
Metformin—Discomfort—Epirubicin—breast cancer	2.46e-05	0.000217	CcSEcCtD
Metformin—Asthenia—Capecitabine—breast cancer	2.46e-05	0.000216	CcSEcCtD
Metformin—Malaise—Doxorubicin—breast cancer	2.44e-05	0.000215	CcSEcCtD
Metformin—Anorexia—Methotrexate—breast cancer	2.44e-05	0.000214	CcSEcCtD
Metformin—Syncope—Doxorubicin—breast cancer	2.43e-05	0.000214	CcSEcCtD
Metformin—Pruritus—Capecitabine—breast cancer	2.43e-05	0.000213	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—breast cancer	2.43e-05	0.000213	CcSEcCtD
Metformin—Palpitations—Doxorubicin—breast cancer	2.4e-05	0.000211	CcSEcCtD
Metformin—Oedema—Epirubicin—breast cancer	2.39e-05	0.00021	CcSEcCtD
Metformin—Hypotension—Methotrexate—breast cancer	2.39e-05	0.00021	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—breast cancer	2.38e-05	0.000209	CcSEcCtD
Metformin—Infection—Epirubicin—breast cancer	2.38e-05	0.000209	CcSEcCtD
Metformin—Shock—Epirubicin—breast cancer	2.35e-05	0.000207	CcSEcCtD
Metformin—Diarrhoea—Capecitabine—breast cancer	2.35e-05	0.000206	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—breast cancer	2.34e-05	0.000206	CcSEcCtD
Metformin—Dizziness—Docetaxel—breast cancer	2.34e-05	0.000206	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—breast cancer	2.34e-05	0.000206	CcSEcCtD
Metformin—Hypertension—Doxorubicin—breast cancer	2.34e-05	0.000206	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.33e-05	0.000205	CcSEcCtD
Metformin—Skin disorder—Epirubicin—breast cancer	2.32e-05	0.000204	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—breast cancer	2.31e-05	0.000203	CcSEcCtD
Metformin—Chest pain—Doxorubicin—breast cancer	2.31e-05	0.000203	CcSEcCtD
Metformin—Myalgia—Doxorubicin—breast cancer	2.31e-05	0.000203	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—breast cancer	2.29e-05	0.000202	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.29e-05	0.000201	CcSEcCtD
Metformin—Discomfort—Doxorubicin—breast cancer	2.28e-05	0.0002	CcSEcCtD
Metformin—Anorexia—Epirubicin—breast cancer	2.28e-05	0.0002	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—breast cancer	2.28e-05	0.0002	CcSEcCtD
Metformin—Somnolence—Methotrexate—breast cancer	2.27e-05	0.0002	CcSEcCtD
Metformin—Dizziness—Capecitabine—breast cancer	2.27e-05	0.000199	CcSEcCtD
Metformin—Vomiting—Docetaxel—breast cancer	2.25e-05	0.000198	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—breast cancer	2.25e-05	0.000198	CcSEcCtD
Metformin—Rash—Docetaxel—breast cancer	2.24e-05	0.000196	CcSEcCtD
Metformin—Hypotension—Epirubicin—breast cancer	2.23e-05	0.000196	CcSEcCtD
Metformin—Dermatitis—Docetaxel—breast cancer	2.23e-05	0.000196	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—breast cancer	2.22e-05	0.000195	CcSEcCtD
Metformin—Headache—Docetaxel—breast cancer	2.22e-05	0.000195	CcSEcCtD
Metformin—Oedema—Doxorubicin—breast cancer	2.21e-05	0.000194	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—breast cancer	2.21e-05	0.000194	CcSEcCtD
Metformin—Fatigue—Methotrexate—breast cancer	2.2e-05	0.000194	CcSEcCtD
Metformin—Infection—Doxorubicin—breast cancer	2.2e-05	0.000193	CcSEcCtD
Metformin—Vomiting—Capecitabine—breast cancer	2.18e-05	0.000192	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.18e-05	0.000191	CcSEcCtD
Metformin—Shock—Doxorubicin—breast cancer	2.18e-05	0.000191	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—breast cancer	2.17e-05	0.000191	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—breast cancer	2.17e-05	0.00019	CcSEcCtD
Metformin—Rash—Capecitabine—breast cancer	2.16e-05	0.00019	CcSEcCtD
Metformin—Dermatitis—Capecitabine—breast cancer	2.16e-05	0.00019	CcSEcCtD
Metformin—Headache—Capecitabine—breast cancer	2.15e-05	0.000189	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—breast cancer	2.15e-05	0.000189	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—breast cancer	2.15e-05	0.000189	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—breast cancer	2.14e-05	0.000188	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—breast cancer	2.13e-05	0.000187	CcSEcCtD
Metformin—Somnolence—Epirubicin—breast cancer	2.13e-05	0.000187	CcSEcCtD
Metformin—Anorexia—Doxorubicin—breast cancer	2.11e-05	0.000185	CcSEcCtD
Metformin—Nausea—Docetaxel—breast cancer	2.11e-05	0.000185	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—breast cancer	2.11e-05	0.000185	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—breast cancer	2.1e-05	0.000185	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—breast cancer	2.09e-05	0.000184	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—breast cancer	2.08e-05	0.000183	CcSEcCtD
Metformin—Hypotension—Doxorubicin—breast cancer	2.07e-05	0.000182	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—breast cancer	2.06e-05	0.000181	CcSEcCtD
Metformin—Fatigue—Epirubicin—breast cancer	2.06e-05	0.000181	CcSEcCtD
Metformin—Constipation—Epirubicin—breast cancer	2.04e-05	0.00018	CcSEcCtD
Metformin—Nausea—Capecitabine—breast cancer	2.04e-05	0.000179	CcSEcCtD
Metformin—Urticaria—Methotrexate—breast cancer	2.03e-05	0.000178	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—breast cancer	2.02e-05	0.000178	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.02e-05	0.000177	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—breast cancer	1.99e-05	0.000175	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—breast cancer	1.97e-05	0.000173	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—breast cancer	1.97e-05	0.000173	CcSEcCtD
Metformin—Somnolence—Doxorubicin—breast cancer	1.97e-05	0.000173	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—breast cancer	1.96e-05	0.000172	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—breast cancer	1.95e-05	0.000171	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—breast cancer	1.92e-05	0.000169	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—breast cancer	1.91e-05	0.000168	CcSEcCtD
Metformin—Fatigue—Doxorubicin—breast cancer	1.91e-05	0.000168	CcSEcCtD
Metformin—Urticaria—Epirubicin—breast cancer	1.9e-05	0.000167	CcSEcCtD
Metformin—Constipation—Doxorubicin—breast cancer	1.89e-05	0.000166	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—breast cancer	1.89e-05	0.000166	CcSEcCtD
Metformin—Asthenia—Methotrexate—breast cancer	1.83e-05	0.000161	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—breast cancer	1.82e-05	0.00016	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—breast cancer	1.81e-05	0.000159	CcSEcCtD
Metformin—Pruritus—Methotrexate—breast cancer	1.81e-05	0.000159	CcSEcCtD
Metformin—Urticaria—Doxorubicin—breast cancer	1.76e-05	0.000154	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—breast cancer	1.75e-05	0.000154	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—breast cancer	1.75e-05	0.000154	CcSEcCtD
Metformin—Asthenia—Epirubicin—breast cancer	1.72e-05	0.000151	CcSEcCtD
Metformin—Pruritus—Epirubicin—breast cancer	1.69e-05	0.000149	CcSEcCtD
Metformin—Dizziness—Methotrexate—breast cancer	1.69e-05	0.000148	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—breast cancer	1.64e-05	0.000144	CcSEcCtD
Metformin—Vomiting—Methotrexate—breast cancer	1.62e-05	0.000143	CcSEcCtD
Metformin—Rash—Methotrexate—breast cancer	1.61e-05	0.000142	CcSEcCtD
Metformin—Dermatitis—Methotrexate—breast cancer	1.61e-05	0.000141	CcSEcCtD
Metformin—Headache—Methotrexate—breast cancer	1.6e-05	0.000141	CcSEcCtD
Metformin—Asthenia—Doxorubicin—breast cancer	1.59e-05	0.00014	CcSEcCtD
Metformin—Dizziness—Epirubicin—breast cancer	1.58e-05	0.000139	CcSEcCtD
Metformin—Pruritus—Doxorubicin—breast cancer	1.57e-05	0.000138	CcSEcCtD
Metformin—Vomiting—Epirubicin—breast cancer	1.52e-05	0.000134	CcSEcCtD
Metformin—Nausea—Methotrexate—breast cancer	1.52e-05	0.000133	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—breast cancer	1.51e-05	0.000133	CcSEcCtD
Metformin—Rash—Epirubicin—breast cancer	1.51e-05	0.000132	CcSEcCtD
Metformin—Dermatitis—Epirubicin—breast cancer	1.51e-05	0.000132	CcSEcCtD
Metformin—Headache—Epirubicin—breast cancer	1.5e-05	0.000132	CcSEcCtD
Metformin—Dizziness—Doxorubicin—breast cancer	1.46e-05	0.000129	CcSEcCtD
Metformin—Nausea—Epirubicin—breast cancer	1.42e-05	0.000125	CcSEcCtD
Metformin—Vomiting—Doxorubicin—breast cancer	1.41e-05	0.000124	CcSEcCtD
Metformin—Rash—Doxorubicin—breast cancer	1.39e-05	0.000123	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—breast cancer	1.39e-05	0.000122	CcSEcCtD
Metformin—Headache—Doxorubicin—breast cancer	1.39e-05	0.000122	CcSEcCtD
Metformin—Nausea—Doxorubicin—breast cancer	1.31e-05	0.000115	CcSEcCtD
Metformin—ND1—Metabolism—NOS3—breast cancer	1.57e-06	1.11e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX4—breast cancer	1.57e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SULT1A1—breast cancer	1.57e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NQO1—breast cancer	1.55e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A1—breast cancer	1.55e-06	1.09e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—breast cancer	1.55e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FN1—breast cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—IDH1—breast cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA1—breast cancer	1.53e-06	1.08e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA4—breast cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA9—breast cancer	1.52e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP3A4—breast cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKBIA—breast cancer	1.51e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAT2—breast cancer	1.51e-06	1.06e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—breast cancer	1.5e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1B1—breast cancer	1.49e-06	1.05e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RAF1—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA2—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX2—breast cancer	1.48e-06	1.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HSP90AA1—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX4—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SULT1A1—breast cancer	1.46e-06	1.03e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—breast cancer	1.45e-06	1.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—breast cancer	1.45e-06	1.02e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—breast cancer	1.44e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—IDH1—breast cancer	1.42e-06	1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA1—breast cancer	1.42e-06	1e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOA1—breast cancer	1.42e-06	1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAT2—breast cancer	1.41e-06	9.92e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—STK11—breast cancer	1.4e-06	9.86e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP19A1—breast cancer	1.4e-06	9.86e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—breast cancer	1.38e-06	9.69e-06	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—breast cancer	1.38e-06	9.68e-06	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—breast cancer	1.38e-06	9.68e-06	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—breast cancer	1.38e-06	9.68e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1—breast cancer	1.34e-06	9.44e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT2—breast cancer	1.34e-06	9.43e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MED12—breast cancer	1.33e-06	9.33e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—DPYD—breast cancer	1.33e-06	9.33e-06	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—breast cancer	1.32e-06	9.3e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDOA—breast cancer	1.3e-06	9.19e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—COMT—breast cancer	1.3e-06	9.16e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—breast cancer	1.3e-06	9.12e-06	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—breast cancer	1.29e-06	9.1e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—breast cancer	1.29e-06	9.06e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—breast cancer	1.28e-06	9e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ITPR1—breast cancer	1.27e-06	8.98e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SERPINE1—breast cancer	1.27e-06	8.96e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA3—breast cancer	1.27e-06	8.92e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A2—breast cancer	1.26e-06	8.86e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—breast cancer	1.26e-06	8.85e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—breast cancer	1.24e-06	8.74e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MED12—breast cancer	1.24e-06	8.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—DPYD—breast cancer	1.24e-06	8.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG2—breast cancer	1.23e-06	8.68e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CPT1A—breast cancer	1.23e-06	8.68e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTR—breast cancer	1.23e-06	8.68e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—breast cancer	1.23e-06	8.63e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDOA—breast cancer	1.22e-06	8.56e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOS3—breast cancer	1.22e-06	8.56e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—breast cancer	1.21e-06	8.51e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—breast cancer	1.2e-06	8.48e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HBA1—breast cancer	1.2e-06	8.46e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PLA2G4A—breast cancer	1.19e-06	8.38e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—breast cancer	1.19e-06	8.38e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOR1—breast cancer	1.19e-06	8.38e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA3—breast cancer	1.18e-06	8.31e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A2—breast cancer	1.17e-06	8.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—breast cancer	1.17e-06	8.25e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ACHE—breast cancer	1.17e-06	8.25e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	1.16e-06	8.15e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—breast cancer	1.15e-06	8.12e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAF1—breast cancer	1.15e-06	8.09e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTR—breast cancer	1.15e-06	8.09e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CPT1A—breast cancer	1.15e-06	8.09e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG2—breast cancer	1.15e-06	8.09e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RELA—breast cancer	1.14e-06	8.06e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GPX1—breast cancer	1.14e-06	8.03e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—breast cancer	1.14e-06	8e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A1—breast cancer	1.13e-06	7.95e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—breast cancer	1.13e-06	7.93e-06	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—breast cancer	1.12e-06	7.91e-06	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—breast cancer	1.12e-06	7.91e-06	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—breast cancer	1.12e-06	7.91e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—breast cancer	1.12e-06	7.9e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—breast cancer	1.12e-06	7.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HBA1—breast cancer	1.12e-06	7.88e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—breast cancer	1.12e-06	7.88e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP17A1—breast cancer	1.11e-06	7.81e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS1—breast cancer	1.1e-06	7.73e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO1—breast cancer	1.1e-06	7.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ACHE—breast cancer	1.09e-06	7.69e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—breast cancer	1.09e-06	7.69e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—breast cancer	1.08e-06	7.59e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2D6—breast cancer	1.08e-06	7.58e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA2—breast cancer	1.06e-06	7.44e-06	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—breast cancer	1.06e-06	7.44e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—breast cancer	1.05e-06	7.41e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—breast cancer	1.05e-06	7.41e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP17A1—breast cancer	1.03e-06	7.28e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—breast cancer	1.03e-06	7.27e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—breast cancer	1.03e-06	7.25e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—breast cancer	1.03e-06	7.23e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FASN—breast cancer	1.03e-06	7.22e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO1—breast cancer	1.02e-06	7.21e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS1—breast cancer	1.02e-06	7.21e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BCHE—breast cancer	1.02e-06	7.19e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—breast cancer	1.01e-06	7.1e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—breast cancer	1e-06	7.07e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2D6—breast cancer	1e-06	7.07e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—breast cancer	1e-06	7.06e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—breast cancer	9.95e-07	7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA2—breast cancer	9.85e-07	6.94e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—breast cancer	9.75e-07	6.87e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A1—breast cancer	9.74e-07	6.86e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NQO1—breast cancer	9.74e-07	6.86e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—breast cancer	9.72e-07	6.84e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAV1—breast cancer	9.7e-07	6.83e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—breast cancer	9.69e-07	6.83e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	9.57e-07	6.74e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FASN—breast cancer	9.56e-07	6.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BCHE—breast cancer	9.52e-07	6.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—breast cancer	9.51e-07	6.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP3A4—breast cancer	9.5e-07	6.69e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK8—breast cancer	9.48e-07	6.68e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—breast cancer	9.4e-07	6.62e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1B1—breast cancer	9.34e-07	6.58e-06	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RAF1—breast cancer	9.29e-07	6.54e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSP90AA1—breast cancer	9.16e-07	6.45e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NQO1—breast cancer	9.08e-07	6.39e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A1—breast cancer	9.08e-07	6.39e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—breast cancer	8.99e-07	6.33e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA1—breast cancer	8.91e-07	6.27e-06	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—breast cancer	8.87e-07	6.24e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—breast cancer	8.86e-07	6.24e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP3A4—breast cancer	8.85e-07	6.23e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—breast cancer	8.84e-07	6.22e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STK11—breast cancer	8.78e-07	6.18e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP19A1—breast cancer	8.78e-07	6.18e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—breast cancer	8.76e-07	6.17e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1B1—breast cancer	8.7e-07	6.13e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—breast cancer	8.67e-07	6.1e-06	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	8.66e-07	6.1e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSP90AA1—breast cancer	8.54e-07	6.01e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA1—breast cancer	8.3e-07	5.85e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—breast cancer	8.28e-07	5.83e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STK11—breast cancer	8.18e-07	5.76e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP19A1—breast cancer	8.18e-07	5.76e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—COMT—breast cancer	8.16e-07	5.75e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—breast cancer	8.12e-07	5.72e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—breast cancer	8.06e-07	5.67e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—breast cancer	8.04e-07	5.66e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—breast cancer	8.01e-07	5.64e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ITPR1—breast cancer	7.99e-07	5.63e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—breast cancer	7.88e-07	5.55e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—breast cancer	7.77e-07	5.47e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—breast cancer	7.69e-07	5.42e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—breast cancer	7.67e-07	5.4e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—COMT—breast cancer	7.61e-07	5.36e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—breast cancer	7.57e-07	5.33e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—breast cancer	7.55e-07	5.32e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—breast cancer	7.47e-07	5.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—breast cancer	7.47e-07	5.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOR1—breast cancer	7.47e-07	5.26e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLA2G4A—breast cancer	7.47e-07	5.26e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ITPR1—breast cancer	7.45e-07	5.25e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—breast cancer	7.44e-07	5.24e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NOS3—breast cancer	7.34e-07	5.17e-06	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—breast cancer	7.24e-07	5.1e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—breast cancer	7.17e-07	5.05e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPX1—breast cancer	7.15e-07	5.03e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A1—breast cancer	7.08e-07	4.98e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—breast cancer	7.04e-07	4.96e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—breast cancer	7.02e-07	4.94e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLA2G4A—breast cancer	6.96e-07	4.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOR1—breast cancer	6.96e-07	4.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—breast cancer	6.96e-07	4.9e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—breast cancer	6.84e-07	4.82e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—breast cancer	6.77e-07	4.77e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—breast cancer	6.71e-07	4.73e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPX1—breast cancer	6.66e-07	4.69e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—breast cancer	6.62e-07	4.66e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—breast cancer	6.6e-07	4.65e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A1—breast cancer	6.6e-07	4.65e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—breast cancer	6.54e-07	4.61e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—breast cancer	6.33e-07	4.46e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—breast cancer	6.15e-07	4.33e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAV1—breast cancer	6.09e-07	4.29e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—breast cancer	6.06e-07	4.26e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—breast cancer	5.85e-07	4.12e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAV1—breast cancer	5.67e-07	3.99e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—breast cancer	5.59e-07	3.93e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—breast cancer	5.54e-07	3.9e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—breast cancer	5.17e-07	3.64e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—breast cancer	4.87e-07	3.43e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—breast cancer	4.81e-07	3.39e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NOS3—breast cancer	4.6e-07	3.24e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—breast cancer	4.54e-07	3.2e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—breast cancer	4.48e-07	3.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NOS3—breast cancer	4.29e-07	3.02e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—breast cancer	4.25e-07	2.99e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—breast cancer	4.21e-07	2.96e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—breast cancer	4.13e-07	2.91e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—breast cancer	3.96e-07	2.79e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—breast cancer	3.92e-07	2.76e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—breast cancer	3.67e-07	2.58e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—breast cancer	3.42e-07	2.41e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—breast cancer	3.37e-07	2.37e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—breast cancer	2.59e-07	1.82e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—breast cancer	2.41e-07	1.7e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—breast cancer	2.12e-07	1.49e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—breast cancer	1.97e-07	1.39e-06	CbGpPWpGaD
